News > India Likely to Approve 2-Dose Regimen for Covid-19 Vaccines, Four Weeks Apart
India Likely to Approve 2-Dose Regimen for Covid-19 Vaccines, Four Weeks Apart
E-News | 03/01/2021 10:05 AM | Click to read full article
India's drugs regulator is likely to approve administering two doses of the AstraZeneca-Oxford vaccine and another locally developed one by Bharat Biotech, each four weeks apart.
Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines and a final decision is expected to be announced by the agency's chief at a news conference scheduled on Sunday.